Galera Therapeutics - Press Releases

Sep 26, 2022	Galera to Present at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting	View HTML PDF Version
Sep 06, 2022	Galera to Participate in the H.C. Wainwright 24th Annual Global Investment Conference	View HTML PDF Version
Sep 01, 2022	Galera Appoints Eugene P. Kennedy, M.D., F.A.C.S., as Chief Medical Officer	View HTML PDF Version
Aug 09, 2022	Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates	View HTML PDF Version
Jun 29, 2022	Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC	View HTML PDF Version
Jun 02, 2022	Galera to Present at Jefferies Healthcare Conference	View HTML PDF Version
May 26, 2022	Galera Announces Oral Presentation at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Detailing Results from Phase 3 ROMAN Trial of Avasopasem	View HTML PDF Version
May 16, 2022	Galera Reports First Quarter 2022 Financial Results and Recent Corporate Updates	View HTML PDF Version
May 16, 2022	Galera Announces Plan to Submit Avasopasem NDA by Year End	View HTML PDF Version
May 02, 2022	Galera Announces Topline Results from Phase 2a AESOP Trial of Avasopasem for Chemoradiotherapy-Induced Esophagitis	View HTML PDF Version